Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sterry

Showing results (261-270 of 329) with videos related to

Pageof 33
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2002
Temporary shielding of hot spots in the drainage areas of cutaneous melanoma improves accuracy of lymphoscintigraphic sentinel lymph node diagnosticsS Maza, R Valencia, L Geworski, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|December 29, 2000
[Ultrasound-guided fine needle aspiration cytology (FNAC) of unclear lesions in melanoma patients]C Voit, T Mayer, T Proebstle, et al.
Archives of Dermatological Research|January 1, 1988
C-type particles are inducible in Se-Ax, a continuous T-cell line from a patient with Sézary's syndromeK Kaltoft, S Bisballe, H F Rasmussen, et al.
Skin Pharmacology and Physiology|June 5, 2008
Hair follicles--an efficient storage and penetration pathway for topically applied substances. Summary of recent results obtained at the Center of Experimental and Applied Cutaneous Physiology, Charité -Universitätsmedizin Berlin, GermanyJ Lademann, F Knorr, H Richter, et al.
Anticancer Research|June 17, 2009
The pathogenetic mechanism of anthracycline-induced palmar-plantar erythrodysesthesiaA Martschick, J Sehouli, Alexa Patzelt, et al.
Genes and Immunity|October 3, 2009
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokinesK Witte, G Gruetz, H-D Volk, et al.
The Journal of Clinical Investigation|March 21, 1998
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approachK Asadullah, W Sterry, K Stephanek, et al.
Journal of the American Academy of Dermatology|May 1, 1997
Verrucosis of hands and feet in a patient with combined immune deficiencyK Asadullah, H Renz, W D Döcke, et al.
Archives of Dermatology|March 3, 1999
Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trialK Asadullah, W D Döcke, M Ebeling, et al.
Skin Pharmacology and Physiology|January 12, 2013
Photoprotective properties of the fluorescent europium complex in UV-irradiated skinO Vogt, J Lademann, F Rancan, et al.
Pageof 33

Showing results (261-270 of 329) with videos related to

Sort By:
Pageof 33
European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2002
Temporary shielding of hot spots in the drainage areas of cutaneous melanoma improves accuracy of lymphoscintigraphic sentinel lymph node diagnosticsS Maza, R Valencia, L Geworski, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|December 29, 2000
[Ultrasound-guided fine needle aspiration cytology (FNAC) of unclear lesions in melanoma patients]C Voit, T Mayer, T Proebstle, et al.
Archives of Dermatological Research|January 1, 1988
C-type particles are inducible in Se-Ax, a continuous T-cell line from a patient with Sézary's syndromeK Kaltoft, S Bisballe, H F Rasmussen, et al.
Skin Pharmacology and Physiology|June 5, 2008
Hair follicles--an efficient storage and penetration pathway for topically applied substances. Summary of recent results obtained at the Center of Experimental and Applied Cutaneous Physiology, Charité -Universitätsmedizin Berlin, GermanyJ Lademann, F Knorr, H Richter, et al.
Anticancer Research|June 17, 2009
The pathogenetic mechanism of anthracycline-induced palmar-plantar erythrodysesthesiaA Martschick, J Sehouli, Alexa Patzelt, et al.
Genes and Immunity|October 3, 2009
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokinesK Witte, G Gruetz, H-D Volk, et al.
The Journal of Clinical Investigation|March 21, 1998
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approachK Asadullah, W Sterry, K Stephanek, et al.
Journal of the American Academy of Dermatology|May 1, 1997
Verrucosis of hands and feet in a patient with combined immune deficiencyK Asadullah, H Renz, W D Döcke, et al.
Archives of Dermatology|March 3, 1999
Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trialK Asadullah, W D Döcke, M Ebeling, et al.
Skin Pharmacology and Physiology|January 12, 2013
Photoprotective properties of the fluorescent europium complex in UV-irradiated skinO Vogt, J Lademann, F Rancan, et al.
Pageof 33